vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and UNITIL CORP (UTL). Click either name above to swap in a different company.

UNITIL CORP is the larger business by last-quarter revenue ($161.5M vs $121.8M, roughly 1.3× Core Laboratories Inc.). UNITIL CORP runs the higher net margin — 11.8% vs 4.2%, a 7.6% gap on every dollar of revenue. On growth, UNITIL CORP posted the faster year-over-year revenue change (26.7% vs -1.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-36.3M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -4.9%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Unitil Corporation is an interstate electricity and natural gas utility company that provides services for New Hampshire, Massachusetts and Maine. Its earliest predecessor company, the Portland Gas Light Company, was founded in Maine in 1849. The current company was set up in 1984 and is based in New Hampshire. With a market cap of 686.51M, it provides electric services to about 102,400 customers and natural gas to over 75,900 customers. The service territory of Unitil includes business distr...

CLB vs UTL — Head-to-Head

Bigger by revenue
UTL
UTL
1.3× larger
UTL
$161.5M
$121.8M
CLB
Growing faster (revenue YoY)
UTL
UTL
+28.1% gap
UTL
26.7%
-1.4%
CLB
Higher net margin
UTL
UTL
7.6% more per $
UTL
11.8%
4.2%
CLB
More free cash flow
CLB
CLB
$36.8M more FCF
CLB
$517.0K
$-36.3M
UTL
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-4.9%
UTL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
UTL
UTL
Revenue
$121.8M
$161.5M
Net Profit
$5.1M
$19.0M
Gross Margin
Operating Margin
1.5%
21.5%
Net Margin
4.2%
11.8%
Revenue YoY
-1.4%
26.7%
Net Profit YoY
21.8%
EPS (diluted)
$0.11
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
UTL
UTL
Q1 26
$121.8M
Q4 25
$138.3M
$161.5M
Q3 25
$134.5M
$101.1M
Q2 25
$130.2M
$102.6M
Q1 25
$123.6M
$170.8M
Q4 24
$129.2M
$127.5M
Q3 24
$134.4M
$92.9M
Q2 24
$130.6M
$95.7M
Net Profit
CLB
CLB
UTL
UTL
Q1 26
$5.1M
Q4 25
$4.9M
$19.0M
Q3 25
$14.2M
$-300.0K
Q2 25
$10.6M
$4.0M
Q1 25
$-154.0K
$27.5M
Q4 24
$7.4M
$15.6M
Q3 24
$11.7M
$0
Q2 24
$9.0M
$4.3M
Gross Margin
CLB
CLB
UTL
UTL
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
UTL
UTL
Q1 26
1.5%
Q4 25
11.5%
21.5%
Q3 25
15.6%
6.9%
Q2 25
11.7%
13.0%
Q1 25
3.6%
27.0%
Q4 24
11.0%
22.1%
Q3 24
14.7%
6.2%
Q2 24
12.3%
13.0%
Net Margin
CLB
CLB
UTL
UTL
Q1 26
4.2%
Q4 25
3.6%
11.8%
Q3 25
10.6%
-0.3%
Q2 25
8.2%
3.9%
Q1 25
-0.1%
16.1%
Q4 24
5.7%
12.2%
Q3 24
8.7%
Q2 24
6.9%
4.5%
EPS (diluted)
CLB
CLB
UTL
UTL
Q1 26
$0.11
Q4 25
$0.11
$1.05
Q3 25
$0.30
$-0.02
Q2 25
$0.22
$0.25
Q1 25
$0.00
$1.69
Q4 24
$0.15
$0.97
Q3 24
$0.25
$0.00
Q2 24
$0.19
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
UTL
UTL
Cash + ST InvestmentsLiquidity on hand
$22.8M
$15.6M
Total DebtLower is stronger
$670.5M
Stockholders' EquityBook value
$275.1M
$609.6M
Total Assets
$587.7M
$2.1B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
UTL
UTL
Q1 26
$22.8M
Q4 25
$22.7M
$15.6M
Q3 25
$25.6M
$14.6M
Q2 25
$31.2M
$8.5M
Q1 25
$22.1M
$10.2M
Q4 24
$19.2M
$6.3M
Q3 24
$21.5M
$6.3M
Q2 24
$17.7M
$2.8M
Total Debt
CLB
CLB
UTL
UTL
Q1 26
Q4 25
$110.3M
$670.5M
Q3 25
$114.1M
$670.5M
Q2 25
$124.6M
$640.7M
Q1 25
$124.4M
$642.1M
Q4 24
$126.1M
$643.3M
Q3 24
$139.9M
$643.3M
Q2 24
$147.6M
$511.3M
Stockholders' Equity
CLB
CLB
UTL
UTL
Q1 26
$275.1M
Q4 25
$266.0M
$609.6M
Q3 25
$271.3M
$597.2M
Q2 25
$261.3M
$532.8M
Q1 25
$253.4M
$534.1M
Q4 24
$246.6M
$512.5M
Q3 24
$250.7M
$502.4M
Q2 24
$240.3M
$508.8M
Total Assets
CLB
CLB
UTL
UTL
Q1 26
$587.7M
Q4 25
$584.0M
$2.1B
Q3 25
$591.4M
$1.9B
Q2 25
$602.1M
$1.9B
Q1 25
$591.5M
$1.9B
Q4 24
$585.1M
$1.8B
Q3 24
$600.5M
$1.7B
Q2 24
$597.8M
$1.7B
Debt / Equity
CLB
CLB
UTL
UTL
Q1 26
Q4 25
0.41×
1.10×
Q3 25
0.42×
1.12×
Q2 25
0.48×
1.20×
Q1 25
0.49×
1.20×
Q4 24
0.51×
1.26×
Q3 24
0.56×
1.28×
Q2 24
0.61×
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
UTL
UTL
Operating Cash FlowLast quarter
$4.0M
$21.4M
Free Cash FlowOCF − Capex
$517.0K
$-36.3M
FCF MarginFCF / Revenue
0.4%
-22.5%
Capex IntensityCapex / Revenue
35.7%
Cash ConversionOCF / Net Profit
0.77×
1.13×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$-53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
UTL
UTL
Q1 26
$4.0M
Q4 25
$7.9M
$21.4M
Q3 25
$8.5M
$15.6M
Q2 25
$13.9M
$42.2M
Q1 25
$6.7M
$52.1M
Q4 24
$20.6M
$23.3M
Q3 24
$13.1M
$26.1M
Q2 24
$17.1M
$49.9M
Free Cash Flow
CLB
CLB
UTL
UTL
Q1 26
$517.0K
Q4 25
$5.0M
$-36.3M
Q3 25
$6.5M
$-39.0M
Q2 25
$10.4M
$2.0M
Q1 25
$3.9M
$19.5M
Q4 24
$17.4M
$-32.3M
Q3 24
$10.4M
$-31.3M
Q2 24
$14.3M
$13.2M
FCF Margin
CLB
CLB
UTL
UTL
Q1 26
0.4%
Q4 25
3.6%
-22.5%
Q3 25
4.8%
-38.6%
Q2 25
8.0%
1.9%
Q1 25
3.1%
11.4%
Q4 24
13.4%
-25.3%
Q3 24
7.7%
-33.7%
Q2 24
10.9%
13.8%
Capex Intensity
CLB
CLB
UTL
UTL
Q1 26
Q4 25
2.1%
35.7%
Q3 25
1.5%
54.0%
Q2 25
2.7%
39.2%
Q1 25
2.3%
19.1%
Q4 24
2.5%
43.6%
Q3 24
2.0%
61.8%
Q2 24
2.2%
38.3%
Cash Conversion
CLB
CLB
UTL
UTL
Q1 26
0.77×
Q4 25
1.61×
1.13×
Q3 25
0.60×
Q2 25
1.31×
10.55×
Q1 25
1.89×
Q4 24
2.78×
1.49×
Q3 24
1.12×
Q2 24
1.90×
11.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons